TrialTuberculosis (Edinburgh, Scotland)2014
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.
Payam Nahid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papertrialcites it